Category: Healthcare
Quick infos Headquarters: Wilmington, Delaware, United States Trade prices Volume: Market Cap: 17.2B Prev closed: 84.08 Open: 83.73 High: 84.23 Low: 82.68 52 week low: 57 52 week high: 96.33 Dividends: No Dividends Next ER: May 2, 2023 Before Market Opens
About the Company Incyte, Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993.
Earnings History Date EPS / Forecast Revenue / Forecast August 1, 2023 May 2, 2023 0.37 / 0.55808.67M / 856.72MFebruary 7, 2023 0.62 / 0.3926.7M / 878.16MBeat! November 1, 2022 0.6 / 0.57823.3M / 845.6MAugust 2, 2022 0.72 / 0.5608911.4M / 818.49MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jul 28, 2023 63.09 63.15 63.25
62.5
1.3M 0.65% Jul 27, 2023 62.68 62.77 63.35
62.51
1.3M -0.19% Jul 26, 2023 62.8 63.8 63.8
62.53
1.5M -1.55% Jul 25, 2023 63.79 63.94 64.38
63.62
1.3M 0.52% Jul 24, 2023 63.46 64.26 64.5
63.31
973K -1.08% Jul 21, 2023 64.15 64.17 64.39
63.49
1.7M 0.22% Jul 20, 2023 64.01 63.3 64.04
63.11
1.6M 1.76% Jul 19, 2023 62.9 62.26 62.94
62.03
1.5M 1.98% Jul 18, 2023 61.68 61.03 62.77
61.03
1.6M 0.98% Jul 17, 2023 61.08 61.71 61.74
61.05
1.1M -1.1% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US45337C1027 CUSIP: 45337C102 Founded:1991 Employees:980 News
Incyte Non-GAAP EPS of $0.99 beats by $0.12, revenue of $954.61M beats by $44.2M seekingalpha.com Aug 1, 2023 7:04 pm
Incyte Announces Positive Topline Results from Phase 3 Trial Evaluating Ruxolitinib Cream (Opzelura®) in Children with Atopic Dermatitis finance.yahoo.com Aug 1, 2023 4:05 pm
Why Incyte Shares Are Falling Today finance.yahoo.com Aug 1, 2023 2:21 pm
Market Update: INCY, META finance.yahoo.com Aug 1, 2023 12:22 pm
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy? finance.yahoo.com Aug 1, 2023 10:02 am
Incyte (INCY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates finance.yahoo.com Aug 1, 2023 9:30 am
Incyte (INCY) Q1 Earnings and Revenues Miss Estimates finance.yahoo.com Aug 1, 2023 8:15 am
Incyte: Q2 Earnings Snapshot finance.yahoo.com Aug 1, 2023 7:17 am
Is Incyte Corporation (NASDAQ:INCY) Trading At A 49% Discount? finance.yahoo.com Aug 1, 2023 6:52 am Replimune, Incyte to collaborate on squamous cell carcinoma combo seekingalpha.com Aug 1, 2023 5:35 am Incyte Q2 2023 Earnings Preview seekingalpha.com Aug 1, 2023 1:10 am
Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma finance.yahoo.com Jul 31, 2023 4:01 pm
Disney downgraded, Meta Platforms upgraded: Wall Street's top analyst calls finance.yahoo.com Jul 25, 2023 10:06 am
Syndax and Incyte Announce Positive Topline Results from the Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host Disease finance.yahoo.com Jul 24, 2023 7:00 am UPDATE 1-Incyte skin disease cream for children meets main goal in late-stage study finance.yahoo.com Jul 11, 2023 4:45 pm
MHRA Grants Marketing Authorisation for Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents finance.yahoo.com Jul 5, 2023 6:12 am
Q1 2023 Syndax Pharmaceuticals Inc Earnings Call finance.yahoo.com May 9, 2023 9:51 am
4 big analyst cuts: PacWest slashed, stock crashes on sale talks | Pro Recap finance.yahoo.com May 5, 2023 3:11 am Incyte Stock Crumbles As Seasonality Hammers Away At First-Quarter Sales finance.yahoo.com May 2, 2023 4:04 pm
Incyte (INCY) to Report Q2 Earnings: What's in the Cards? finance.yahoo.com Jul 27, 2023 10:20 am This company doesn't provide a dividend.
Key Persons Talk about Incyte Corp. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: incyte.com Consensus BUY 56 HOLD 44 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet